Mitraford 7.5 Tablet MD
Marketer
Oxford Pharmaceuticals Pvt Ltd
Salt Composition
Mirtazapine (7.5mg)
Overview Mitraford 7.5 Tablet MD
Deprexis 7.5mg tablets are indicated for managing depressive disorders. Their mechanism involves elevating brain levels of serotonin and noradrenaline, neurotransmitters that promote calmness and nerve relaxation, thus alleviating depressive symptoms. Deprexis 7.5mg may be administered with or without food; consistent daily dosing is recommended for stable blood levels. Missed doses should be taken upon recollection; complete the prescribed course, even with symptom improvement, and avoid abrupt cessation to prevent symptom exacerbation. Common adverse effects include xerostomia, increased hunger, and cephalgia. Drowsiness and vertigo are also possible; avoid activities demanding concentration until the drug's effects are known. Weight gain is a potential consequence, necessitating a healthy diet and regular physical activity. Report any fever or pharyngitis to your physician while using this medication.
Uses of Mitraford 7.5 Tablet MD
Managing Depressive Disorders
Major Benefits of Mitraford 7.5 Tablet MD:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Mitraford 7.5mg Tablet MD can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Mitraford 7.5 Tablet MD:
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mitraford 7.5 Tablet MD:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Avoid contact with the tablets using damp hands. Place the tablet in your mouth; however, refrain from immediate ingestion. Mitraford 7.5mg Tablet MD can be ingested with or without food, though consistent timing is recommended.
How Mitraford 7.5 Tablet MD works:
Deplin 7.5mg tablets are used to treat depression. Their mechanism of action involves elevating brain levels of serotonin and norepinephrine, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Mitraford 7.5 Tablet MD is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Mitraford 7.5 mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Mitraford 7.5 Tablet MD is likely unsafe. Available data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of the infant's development and behavior is recommended.
DrivingUNSAFE
Driving ability may be compromised by Mitraford 7.5 Tablet MD, due to potential side effects impacting concentration and alertness.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Mitraford 7.5 mg tablets. Dosage modification may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Mitraford 7.5 mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Mitraford 7.5 Tablet MD :
Should you forget a Mitraford 7.5 Tablet MD dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mitraford 7.5 Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Tetracyclic Piperazinoazepine |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Action Class | Norepinephrine and serotonin-specific antidepressants (NaSSAs) |

